Literature DB >> 26975585

Genetic predisposition and hematopoietic malignancies in children: Primary immunodeficiency.

Jutte van der Werff Ten Bosch1, Machiel van den Akker2.   

Abstract

It is assumed that patients with some forms of primary immunodeficiency (PID) have a markedly increased risk of cancer as compared to the healthy population. This increased incidence is seen in children as well as adult patients. The type of malignancy depends on the underlying genetic defect, but hematopoietic cancers are most frequent in almost any subtype of PID. In some patients, a malignancy can even be the first or only symptom of an underlying genetic defect. The possibility of an underlying PID is important for the pediatric oncologist as this might influence the treatment. Also, patients with a known PID should be screened for the occurrence of cancer. It is therefore important to raise awareness on this subject among clinicians involved in the treatment of children with cancer as well as in the treatment of children with PID. Copyright Â
© 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Children; Leukemia; Lymphoma; Primary immuno deficiency

Mesh:

Year:  2016        PMID: 26975585     DOI: 10.1016/j.ejmg.2016.03.001

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  7 in total

Review 1.  Primary immunodeficiencies and their associated risk of malignancies in children: an overview.

Authors:  Samuele Renzi; Karin Petra Sabine Langenberg-Ververgaert; Nicolas Waespe; Salah Ali; Jack Bartram; Orli Michaeli; Julia Upton; Michaela Cada
Journal:  Eur J Pediatr       Date:  2020-03-11       Impact factor: 3.183

2.  Cadherin 17 mutation associated with leaky severe combined immune deficiency is corrected by HSCT.

Authors:  Angela R Smith; Ioanna A Rota; Stefano Maio; Michel J Massaad; Troy C Lund; Luigi D Notarangelo; Georg A Holländer; Bruce R Blazar
Journal:  Blood Adv       Date:  2017-10-23

Review 3.  Germline Genetic Predisposition to Hematologic Malignancy.

Authors:  Elissa Furutani; Akiko Shimamura
Journal:  J Clin Oncol       Date:  2017-02-13       Impact factor: 44.544

4.  Differing Performance of the Warning Signs for Immunodeficiency in the Diagnosis of Pediatric Versus Adult Patients in a Two-Center Tertiary Referral Population.

Authors:  Jaclyn A Bjelac; Jennifer R Yonkof; James Fernandez
Journal:  J Clin Immunol       Date:  2019-01-04       Impact factor: 8.317

Review 5.  A Tumor Profile in Primary Immune Deficiencies Challenges the Cancer Immune Surveillance Concept.

Authors:  Daniel Satgé
Journal:  Front Immunol       Date:  2018-05-24       Impact factor: 7.561

6.  Severe immunodeficiency associated with acute lymphoblastic leukemia and its treatment.

Authors:  Nikita Raje; Brenda L Snyder; David A Hill; Jenna L Streicher; Kate E Sullivan
Journal:  Ann Allergy Asthma Immunol       Date:  2018-03-19       Impact factor: 6.347

Review 7.  Inborn Errors of Immunity and Cancer.

Authors:  Alessandra Tiri; Riccardo Masetti; Francesca Conti; Anna Tignanelli; Elena Turrini; Patrizia Bertolini; Susanna Esposito; Andrea Pession
Journal:  Biology (Basel)       Date:  2021-04-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.